An international collaborative study of the effect of active pertussis toxin on the modified Kendrick test for acellular pertussis vaccines
- 1 March 2014
- journal article
- Published by Elsevier in Biologicals
- Vol. 42 (2) , 101-108
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- WHO Working Group on the standardisation and control of pertussis vaccines—report of a meeting held on 6–7 May 2003, Ferney Voltaire, FranceVaccine, 2004
- Ad hoc Working Group on acellular pertussis vaccines, World Health Organisation, Geneva, 27-28 July 2000.Vaccine, 2001
- Informal Consultation with Manufacturers and WHO Ad Hoc Working Group on Mouse Protection Models for Acellular Pertussis Vaccines National Institute for Biological Standards, 12 November 1998Biologicals, 1999
- Comparative Efficacy of the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine and Lederle Whole-Cell Component DTP Vaccine in German Children After Household ExposurePediatrics, 1998
- Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccineThe Lancet, 1997
- A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in SenegalVaccine, 1997
- A Controlled Trial of a Two-Component Acellular, a Five-Component Acellular, and a Whole-Cell Pertussis VaccineNew England Journal of Medicine, 1996
- A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against PertussisNew England Journal of Medicine, 1996
- A Placebo-Controlled Trial of a Pertussis-Toxoid VaccineNew England Journal of Medicine, 1995
- Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in GermanyVaccine, 1994